Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...
Brain Organoids in Alzheimer’s Disease Research: Applications, Limitations, and Future Directions ()
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which molecular pathology, cellular stress and network dysfunction accumulate over many years before dementia becomes clinically ...
HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results